Liz Highleyman

Despite these advances, Black women are still twice as likely as white women to die of breast cancer.

Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.

Tecentriq after surgery and chemotherapy delayed recurrence in people with Stage II or III non-small-cell lung cancer.

Prolonged delays in cancer screening for low-income women during the pandemic threaten to increase existing health disparities.

Some people with blood cancers, however, may not be as well protected.

National LGBT Cancer Network releases largest-ever survey of LGBTQIA+ cancer survivors.

A companion study will look at liver biopsy results to confirm these findings from noninvasive tests.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.

Alzheimer’s advocates laud the approval of Aduhelm, but experts raise questions about its effectiveness and cost.

Cancer screenings have dropped precipitously due to the COVID-19 pandemic.

It’s well known that some viruses can cause cancer—but others are cancer killers.

The Food and Drug Administration created its accelerated approval program to enable more rapid approval of therapies for serious conditions.

Here are the latest new cancer drugs approved by the Food and Drug Administration.

Several new medications for kidney cancer have been approved in recent years.

PARP inhibitor reduces the risk of disease recurrence in BRCA-positive people with high-risk early breast cancer.